SCHEMBL1058083

SCHEMBL1058083

CC(CC(C)P(C1CCCCC1)C1CCCCC1)P(C1CCCCC1)C1CCCCC1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2923689 0.83 SHBG (0.41) SHBG
SCHEMBL3170657 0.80 SHBG (0.37) SHBG
SCHEMBL3901953 0.79
SCHEMBL3411778 0.79 ACE (0.30)
SCHEMBL3901923 0.76
SCHEMBL10773183 0.76 CYP1A2 (0.39) SHBG
SCHEMBL23832132 0.76 SHBG (0.31) SHBG
SCHEMBL6032750 0.76 SHBG (0.31) SHBG
SCHEMBL19464111 0.76 SHBG (0.31) SHBG
SCHEMBL798743 0.76 SHBG (0.31) SHBG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062361-A1 PROCESS FOR THE PREPARATION OF BIO-BASED OLEFINS FROM PRIMARY ALCOHOL BASF SE (DE) 2026-03-05 US claimed
US-20240101516-A1 SYNTHESIS OF POLYFLUORINATED ARYL AND HETEROARYL CARBOXAMIDES BASF SE (DE) 2024-03-28 US claimed
WO-2024038044-A1 PROCESS FOR THE PREPARATION OF BIO-BASED OLEFINS FROM PRIMARY ALCOHOL BASF SE (DE) 2024-02-22 WO claimed
EP-4281436-A1 SYNTHESIS OF POLYFLUORINATED ARYL AND HETEROARYL CARBOXAMIDES BASF SE (DE) 2023-11-29 EP claimed
CN-116724021-A Synthesis of polyfluorinated aryl and heteroaryl carboxamides 巴斯夫欧洲公司 2023-09-08 CN claimed
US-20230100114-A1 PD-CATALYZED AMINATION OF FLUORINATED ARYL CHLORIDES BASF SE (DE) 2023-03-30 US claimed
EP-4132902-A1 PD-CATALYZED AMINATION OF FLUORINATED ARYL CHLORIDES BASF SE (DE) 2023-02-15 EP claimed
EP-3818038-B1 PROCESS FOR THE PRODUCTION OF ARYLAMINES MERCK PATENT GMBH (DE) 2022-08-03 EP claimed
WO-2022157106-A1 SYNTHESIS OF POLYFLUORINATED ARYL AND HETEROARYL CARBOXAMIDES BASF SE (DE) 2022-07-28 WO claimed
US-20220127251-A1 PROCESS FOR THE PRODUCTION OF ARYLAMINES MERCK PATENT GMBH (DE) 2022-04-28 US claimed
EP-3818038-A1 PROCESS FOR THE PRODUCTION OF ARYLAMINES Merck Patent GmbH (DE) 2021-05-12 EP claimed
WO-2020007770-A1 PROCESS FOR THE PRODUCTION OF ARYLAMINES MERCK PATENT GMBH (DE) 2020-01-09 WO claimed
US-9266806-B1 Reductive carbonylation of methanol to acetaldehyde EASTMAN CHEMICAL COMPANY (US) 2016-02-23 US claimed
US-20260062361-A1 PROCESS FOR THE PREPARATION OF BIO-BASED OLEFINS FROM PRIMARY ALCOHOL BASF SE (DE) 2026-03-05 US disclosed
CN-119731143-A Process for the preparation of biobased olefins from primary alcohols 巴斯夫欧洲公司 2025-03-28 CN disclosed
US-20240101516-A1 SYNTHESIS OF POLYFLUORINATED ARYL AND HETEROARYL CARBOXAMIDES BASF SE (DE) 2024-03-28 US disclosed
WO-1998015515-A1 SYNTHESIS OF ARYL ETHERS, METHODS AND REAGENTS RELATED THERETO MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1998-04-16 WO disclosed
US-5639883-A Process for preparing substituted 4-methylidenecinnamic acid derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1997-06-17 US disclosed
EP-0696568-A1 Process for preparing substituted 4-methylidene cinnamic acid derivatives as well as novel methylidene cinnamic acid derivatives MERCK PATENT GmbH (DE) 1996-02-14 EP disclosed
WO-1995023126-A1 PROCESS FOR THE PREPARATION OF CINNAMIC ACID DERIVATIVES MERCK PATENT GMBH (DE) 1995-08-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127251-A1 PROCESS FOR THE PRODUCTION OF ARYLAMINES MAOB, TYR, INMT SHBG 4343/4885
US-20240101516-A1 SYNTHESIS OF POLYFLUORINATED ARYL AND HETEROARYL CARBOXAMIDES AADAC, PAICS, PARN SHBG 4857/4885
US-20230100114-A1 PD-CATALYZED AMINATION OF FLUORINATED ARYL CHLORIDES DDC, DDT, AOC1 SHBG 4757/4885
US-20260062361-A1 PROCESS FOR THE PREPARATION OF BIO-BASED OLEFINS FROM PRIMARY ALCOHOL ADH1C, ADH5, ADH1A SHBG 3731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.